Transformation of a prostatic adenocarcinoma into squamous cell carcinoma after luteinizing hormone-releasing hormone (LHRH) agonist and radiotherapy treatment

被引：1

作者：

Ichaoui, Hamza ^{[1
,2
]}

Ben Nasr, Sonia ^{[1
,3
]}

Gargouri, Faten ^{[1
,4
]}

Zribi, Aref ^{[1
,3
]}

Hermi, Amine ^{[1
,2
]}

Fendri, Sana ^{[1
,3
]}

Balti, Mehdi ^{[1
,3
]}

Ayari, Jihen ^{[1
,3
]}

Khiari, Ramzi ^{[1
,2
]}

Msakni, Issam ^{[1
,4
]}

Mansouri, Nada ^{[1
,4
]}

Ghozzi, Samir ^{[1
,2
]}

Haddaoui, Abderrazek ^{[1
,3
]}

机构：

[1] Univ Tunis El Manar, Fac Med Tunis, Tunis 1007, Tunisia

[2] Mil Hosp Tunis, Dept Urol, Montfleury 1008, Tunisia

[3] Mil Hosp Tunis, Dept Med Oncol, Montfleury 1008, Tunisia

[4] Mil Hosp Tunis, Dept Pathol, Montfleury 1008, Tunisia

来源：

PAN AFRICAN MEDICAL JOURNAL | 2019年 / 34卷

关键词：

Prostate; squamous cell carcinoma; hormonotherapy; ADENOSQUAMOUS CARCINOMA;

D O I：

10.11604/pamj.2019.34.125.19421

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Squamous cell carcinoma of the prostate is rare and represents 0.5% to 1% of prostatic carcinomas. Transformation of prostatic adenocarcinoma into squamous cell carcinoma after LH-RH agonist intake has been reported in only 8 cases in the literature. To our knowledge, our case is the second pure squamous cell carcinoma observed after hormonotherapy and radiotherapy. We reported a case of a patient with prostatic adenocarcinoma treated by radical prostatectomy followed by radiotherapy. Eleven years later, he had a vesical recurrence of prostatic adenocarcinoma. Our patient had an endoscopic resection followed by injections of Triptorelin. Six months later, he developed a local recurrence of a squamous cell carcinoma.

引用

页数：7